Adjuvant treatment of colon cancer with microsatellite instability – the state of the art
-
Published:2022-01
Issue:
Volume:169
Page:103537
-
ISSN:1040-8428
-
Container-title:Critical Reviews in Oncology/Hematology
-
language:en
-
Short-container-title:Critical Reviews in Oncology/Hematology
Author:
Oneda EsterORCID,
Zaniboni Alberto
Subject
Oncology,Hematology
Reference68 articles.
1. Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial;Alberts;Jama,2012
2. Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08;Allegra;J Clin Oncol,2011
3. The Landmark Series: Chemotherapy for Non-Metastatic Colon Cancer;Alonso;Ann Surg Oncol,2020
4. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial;André;J Clin Oncol,2009
5. Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study;André;J Clin Oncol,2015
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献